Amanote Research

Amanote Research

    RegisterSign In

Mutations in Epigenetic Modifiers in Myeloid Malignancies and the Prospect of Novel Epigenetic-Targeted Therapy

Advances in Hematology - Egypt
doi 10.1155/2012/469592
Full Text
Open PDF
Abstract

Available in full text

Categories
Hematology
Date

January 1, 2012

Authors
Amir T. FathiOmar Abdel-Wahab
Publisher

Hindawi Limited


Related search

Awareness of Emerging Novel Epigenetic Targeting Therapy in Acute Myeloid Leukemia

Cancer therapy & Oncology International Journal
2018English

Epigenetic Therapy Combinations in Acute Myeloid Leukemia: What Are the Options?

Therapeutic Advances in Hematology
Hematology
2019English

“Epigenetic” Modification as Therapy for Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2017English

Emerging Concepts of Epigenetic Dysregulation in Hematological Malignancies

Nature Immunology
AllergyImmunology
2016English

Epigenetic Regulation of Myeloid Cells

2017English

Epigenetic-Targeted Drug Discovery

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2011English

Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies

PLoS ONE
Multidisciplinary
2011English

Epigenetic Inactivation of the Hsa-miR-203 in Haematological Malignancies

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2011English

The Epigenetic Landscape of Acute Myeloid Leukemia

Advances in Hematology
Hematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy